Abstract |
Immunotherapy holds great promise for Alzheimer's disease (AD), but meningoencephalitis observed in the first AD vaccination trial, which accompanied T-lymphocytic infiltration, needs to be overcome. This study was aimed to investigate alternative approaches for a safer vaccine to treat AD. We used intramembranous fragment of amyloid-beta (IF-Abeta) to immunize Kunming mice for up to 2.5 months and then evaluated the immunization efficacy and potential adverse effects. Immunization of mice with IF-Abeta plus Freund's adjuvant resulted in moderate levels of Abeta antibodies ( IgG), and the anti-sera were able to neutralize Abeta1-42-neurotoxicity in cultured primary cortical neurons. IF-Abeta itself did not show neurotoxicity, and immunization with IF-Abeta did not cause behavioral deficits in Morris water maze or any abnormalities by histological examinations of major organs including the brain. We conclude that vaccination with IF-Abeta may be a potentially safe and effective treatment for AD.
|
Authors | Songjiang Zhang, Lixiang Wu, Fayi Liu, Bosheng Huang, Dong Huang, Lijuan Yang, Zhihong Peng |
Journal | Neurochemical research
(Neurochem Res)
Vol. 34
Issue 11
Pg. 1889-95
(Nov 2009)
ISSN: 1573-6903 [Electronic] United States |
PMID | 19347579
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid beta-Peptides
- Immune Sera
- Immunoglobulin G
- Peptide Fragments
- amyloid beta-protein (1-42)
|
Topics |
- Alzheimer Disease
(immunology, therapy)
- Amyloid beta-Peptides
(immunology, toxicity)
- Animals
- Antibody Formation
- Cells, Cultured
- Cerebral Cortex
(drug effects, pathology)
- Immune Sera
- Immunoglobulin G
(blood)
- Immunotherapy
- Kidney
(drug effects, pathology)
- Liver
(drug effects, pathology)
- Male
- Maze Learning
(drug effects)
- Memory
(drug effects)
- Mice
- Neurons
(drug effects, pathology)
- Peptide Fragments
(adverse effects, immunology, toxicity)
- Spleen
(drug effects, pathology)
|